...
首页> 外文期刊>British Journal of Cancer >Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma
【24h】

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma

机译:淋巴细胞归巢受体(CD44)表达与胃肠道淋巴瘤预后不良有关

获取原文

摘要

Lymphocyte homing receptor (CD44) is involved in lymphocyte adhesion to endothelial cells of high endothelial venules (HEVs) and lymphocyte exit from the blood circulation, and it may be involved also in hematogenous dissemination of malignant lymphoma. Prognostic significance of lymphocyte homing receptor expression defined by Hermes-3 antibody was studied among 27 gastrointestinal lymphomas followed up for 8 to 20 years after the diagnosis. Lymphomas lacking or with very weak homing receptor expression (n = 14, 52%) were associated with 57% 10-year survival rate as compared with only 15% among lymphomas that expressed CD44 more strongly (P = 0.02). We conclude that lack of lymphocyte homing receptor expression is common in gastrointestinal lymphoma, and that CD44 expression is associated with unfavourable prognosis.
机译:淋巴细胞归巢受体(CD44)参与淋巴细胞与高内皮小静脉(HEVs)内皮细胞的粘附和淋巴细胞从血液循环中排出,并且还可能参与恶性淋巴瘤的血行性传播。在诊断后随访了8至20年的27例胃肠道淋巴瘤中,研究了由Hermes-3抗体定义的淋巴细胞归巢受体表达的预后意义。缺乏或具有非常弱的归巢受体表达的淋巴瘤(n = 14,52%)与57%的10年生存率相关,而在CD44中表达更强的淋巴瘤中只有15%(P = 0.02)。我们得出结论,在胃肠道淋巴瘤中常见缺乏淋巴细胞归巢受体表达,并且CD44表达与不良预后相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号